Stockreport

Asia-Pacific Measurable/Minimal Residual Disease (MRD) Testing Market Analysis 2023-2033 - Medicare Expansion and Rising Consumer Awareness Driving Growth [Yahoo! Finance]

SYSMEX CORP UNSP/ASDR  (SSMXY) 
NASDAQ:AMEX Investor Relations: sysmex.co.jp/en/ir/index.html
PDF The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023- [Read more]